Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Julphar
Johnson and Johnson
McKinsey
Express Scripts
US Army
Dow
Harvard Business School
Healthtrust

Generated: June 21, 2018

DrugPatentWatch Database Preview

METHYLTESTOSTERONE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for methyltestosterone and what is the scope of methyltestosterone patent protection?

Methyltestosterone
is the generic ingredient in nine branded drugs marketed by Heather, Impax Labs Inc, Valeant Pharm Intl, Star Pharms Fl, Schering, Novartis, Impax Labs, Lilly, Purepac Pharm, Pvt Form, Tablicaps, Usl Pharma, Valeant Pharms North, Inwood Labs, Kv Pharm, Lannett, Parke Davis, Watson Labs, and West Ward, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for methyltestosterone. One supplier is listed for this compound.
Pharmacology for METHYLTESTOSTERONE
Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for METHYLTESTOSTERONE
Synonyms for METHYLTESTOSTERONE
(17-beta)-17-Hydroxy-17-methylandrost-4-en-3-one
(17beta)-17-hydroxy-17-methylandrost-4-en-3-one
(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
(1S,2R,10R,11S,14S,15S)-14-HYDROXY-2,14,15-TRIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-5-ONE
(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyltetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadec-6-en-5-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
1050679-28-1
1300-17-0
17 beta-Hydroxy-17-methyl-4-androsten-3-one
17 beta-Methyltestosterone
17-.beta.-Hydroxy-17-methylandrost-4-en-3-one
17-alpha-Methyltestosterone
17-alpha-Methyltestosterone 100 microg/mL in Acetonitrile
17-beta-Hydroxy-17-alpha-methylandrost-4-en-3-on
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-Epimethyltestosterone
17-Hydroxy-17-methyl-3-keto-androstene-4
17-Hydroxy-17-methylandrost-4-en-3-one #
17-Methyltestoster
17-Methyltestosteron
17-Methyltestosterone
17-MT
17.alpha.-methyl-.DELTA.4-androsten-17.beta.-ol-3-one
17.alpha.-Methyl-3-oxo-4-androsten-17.beta.-ol
17.alpha.-Methyltestosterone
17.beta.-Hydroxy-17.alpha.-methylandrost-4-en-3-one
17(alpha)-methyl-Delta(4)-androsten-17(beta)-ol-3-one
17(alpha)-Methyl-delta4-androsten-17(beta)-ol-3-one
17|A-Methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta-androsten-17beta-ol-3-one
17alpha-methyl-Delta(4)-androsten-17beta-ol-3-one
17alpha-methyl-Delta4-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-Methyltestosterone solution, 1.0 mg/mL in 1,2-dimethoxyethane, ampule of 1 mL, certified reference material
17alpha-Methyltestosterone, >=97.0% (HPLC)
17alpha-Methyltestosterone, solid (photosensitive)
17alpha-Methyltestosterone, VETRANAL(TM), analytical standard
17beta-Hydroxy-17-methyl-4-androsten-3-one
17beta-Hydroxy-17-methylandrost-4-en-3-one
17beta-Methyltestosterone
262423-02-9
31745-24-1
4-08-00-01010 (Beilstein Handbook Reference)
4-Androstene-17-alpha-methyl-17-beta-ol-3-one
4-Androstene-17.alpha.-methyl-17.beta.-ol-3-one
4-Androstene-17alpha-methyl-17beta-ol-3-one
58-18-4
AB00443683-06
AB00443683-09
AC1L1LLR
AK113796
AKOS015917317
AN-41744
Android
Android (TN)
Android 10
Android 25
Android 5
Android-10
Android-25
Android-5
Andrometh
Androsan
Androsan (tablets)
Androsan (VAN)
Androsan, tablets
Androst-4-en-3-on-17.beta.-ol, 17.alpha.-methyl
Androst-4-en-3-one, 17-beta-hydroxy-17-methyl-
Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17b)-
Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)-
Androst-4-en-3-one, 17.beta.-hydroxy-17-methyl-
Androst-4-en-3-one, 17beta-hydroxy-17-methyl-
Androst-4-ene-17.alpha.-methyl-17.beta.-ol-3-one
Androsten
Anertan
Anertan (tablets)
Anertan (VAN)
Anertan, tablets
API0003346
BDBM50410531
BRN 2057425
C07198
CAS-58-18-4
CCG-100871
CCRIS 3723
CDB 110
CHEBI:27436
CHEMBL1395
CJ-10774
component of Estan
component of Gynetone
component of Gynetone (Salt/Mix)
component of Tylosterone
Conjugated estrogens / methyltestosterone
Conjugated estrogens mixture with methyltestosterone
CS-5099
D00408
D0Z1XD
DB06710
DSSTox_CID_13664
DSSTox_GSID_33664
DSSTox_RID_79089
DTXSID1033664
Dumogran
EINECS 200-366-3
Estan (Salt/Mix)
Estratest
Estratest (Salt/Mix)
Estratest H.S.
Estratest HS
Estratest-HS
GCKMFJBGXUYNAG-HLXURNFRSA-N
Glosso sterandryl
Glosso-sterandryl
GS-6594
GTPL6945
HMS2051A14
HMS2272A06
Homandren
Homandren (VAN)
Homandren, tablets
Hormale
HSDB 3365
HY-A0121
I14-9703
KB-64817
L 589.372
LMST02020029
LS-19506
M.T.Mucorettes
M0435
Malestrone
Malogen
Masenone
Mastestona
MCULE-5274452426
Mesteron
Mesterone
Metandren
Metestone
Methitest
METHYL TESTOSTERONE
Methyltestosterone (17alpha-Methyltestosterone)
Methyltestosterone (17alpha-Methyltestosterone) 1.0 mg/ml in Acetonitrile
Methyltestosterone (JP17/USP/INN)
Methyltestosterone [USAN:INN:BAN:JAN]
Methyltestosterone [USP:INN:BAN:JAN]
Methyltestosterone for system suitability, European Pharmacopoeia (EP) Reference Standard
Methyltestosterone mixture with conjugated estrogens
Methyltestosterone, European Pharmacopoeia (EP) Reference Standard
Methyltestosterone, United States Pharmacopeia (USP) Reference Standard
Methyltestosteronum
Methyltestosteronum [INN-Latin]
Metiltestosterona
Metiltestosterona [INN-Spanish]
Metiltestosterone
Metiltestosterone [DCIT]
Metrone
MFCD00003655
MLS000759474
MLS001424040
MLS002174282
MolPort-003-933-840
Nabolin
NC00121
NCGC00091009-01
NCGC00091009-03
NCGC00091009-04
NCGC00091009-05
NCGC00091009-06
NCGC00091009-07
Neo-Hombreol [M]
Neo-Hombreol-M
Neo-Homobreol (M)
Neo-Homobreol [M]
NSC 139965
NSC-139965
NSC-9701
NSC139965
NSC9701
Nu-man
Oraviron
Orchisterone-M
Oreton M
Oreton Methyl
Oreton-M
Oretron
PL000216
Premarin with methyltestosterone
Premarin with Methyltestosterone (Salt/Mix)
RU 24400
SC-16208
SCHEMBL18657
SMR000058528
SMR001261452
Steronyl
Synandrets
Synandrotabs
Syndren
Testhormone
Testora
Testosterone, 17-methyl-
Testoviron (tablet)
Testoviron (VAN)
Testovis (tablet)
Testovis Depot
Testred
Testred (TN)
TL8003728
Tox21_113161
Tox21_113162
Tox21_113162_1
Tox21_400058
U 2842
UNII-V9EFU16ZIF
V9EFU16ZIF
Virilon
WLN: L E5 B666 OV MUTJ A E FQ F -B&AEF
ZINC3814422

US Patents and Regulatory Information for METHYLTESTOSTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering ORETON methyltestosterone TABLET;BUCCAL 080281-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs METHYLTESTOSTERONE methyltestosterone TABLET;ORAL 080931-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis METANDREN methyltestosterone TABLET;BUCCAL, SUBLINGUAL 003240-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pvt Form METHYLTESTOSTERONE methyltestosterone TABLET;BUCCAL, SUBLINGUAL 083836-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Julphar
Chinese Patent Office
Chubb
McKesson
Citi
Baxter
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.